JP6854815B2 - 酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 - Google Patents
酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 Download PDFInfo
- Publication number
- JP6854815B2 JP6854815B2 JP2018520414A JP2018520414A JP6854815B2 JP 6854815 B2 JP6854815 B2 JP 6854815B2 JP 2018520414 A JP2018520414 A JP 2018520414A JP 2018520414 A JP2018520414 A JP 2018520414A JP 6854815 B2 JP6854815 B2 JP 6854815B2
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- ginsenoside
- saponin
- trichoderma
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930182490 saponin Natural products 0.000 title claims description 44
- 150000007949 saponins Chemical class 0.000 title claims description 43
- 239000001397 quillaja saponaria molina bark Substances 0.000 title claims description 36
- 238000000034 method Methods 0.000 title claims description 20
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 title claims description 19
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 title claims description 19
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 title claims description 19
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 title claims description 19
- 241000208340 Araliaceae Species 0.000 title description 40
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 title description 40
- 235000008434 ginseng Nutrition 0.000 title description 40
- 238000006911 enzymatic reaction Methods 0.000 title description 8
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 241000223259 Trichoderma Species 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 229930182494 ginsenoside Natural products 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003125 aqueous solvent Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 241000223260 Trichoderma harzianum Species 0.000 claims description 2
- -1 diol saponin Chemical class 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims 2
- 235000002767 Daucus carota Nutrition 0.000 claims 2
- 241000499912 Trichoderma reesei Species 0.000 claims 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 1
- 241000723082 Trichoderma aggressivum Species 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 description 40
- 229940088598 enzyme Drugs 0.000 description 19
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 8
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 8
- 108010059820 Polygalacturonase Proteins 0.000 description 5
- 108010093305 exopolygalacturonase Proteins 0.000 description 5
- 108010059892 Cellulase Proteins 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 3
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 2
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 2
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 2
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 2
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- SWIROVJVGRGSPO-UHFFFAOYSA-N Ginsenoside F2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O SWIROVJVGRGSPO-UHFFFAOYSA-N 0.000 description 1
- AVTXSAWPGCSYFO-UHFFFAOYSA-N Ginsenoside Ia Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O AVTXSAWPGCSYFO-UHFFFAOYSA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 description 1
- SWIROVJVGRGSPO-JBVRGBGGSA-N ginsenoside F2 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SWIROVJVGRGSPO-JBVRGBGGSA-N 0.000 description 1
- CJFGBCWGOQRURQ-UHFFFAOYSA-N ginsenoside Mc Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CJFGBCWGOQRURQ-UHFFFAOYSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/12—Acting on D ring
- C12P33/16—Acting at 17 position
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Description
紅参、白参、水参、尾参あるいはこれらの人参の葉、人参の花、人参の実2kgにエタノール20リットル(L)を入れ、3回還流抽出した後、15℃で6日間沈積させた。その後、ろ過布ろ過と遠心分離を通じて残渣とろ液を分離し、分離されたろ液を減圧濃縮して得られたエキスを水に懸濁した後に、エーテル1Lで5回抽出して色素を除去し、水層を1−ブタノール1Lで3回抽出した。これから得られた総1−ブタノール層を5%KOHで処理した後に蒸留水で洗浄し、減圧濃縮して1−ブタノールエキスを収得し、これを少量のメタノールに溶かした後、大量の酢酸エチルに加えて、生成された沈殿物を乾燥させることによって、人参精製サポニン(ジンセノサイドRb1、Rb2、Rc、Rd、Re、Rg1、Rfなどを含む)40〜80gを収得した。
上記参考例1の人参精製サポニン(ジンセノサイドRb1、Rb2、Rc、Rd、Re、Rg1、Rfなどを含む)10gを水1Lに入れて溶解した。
その後、上記混合液にトリコデルマリーゼイから分離したペクチナーゼを基質対比200重量%添加した後、30℃で48時間反応させた。薄層クロマトグラフィーによって周期的に確認して基質が完全に消失されると、沸騰水浴槽で10分間加熱して酵素を不活性化させて、反応を終了させた。最後に反応液に酢酸エチルあるいはエタノールを1:1の比率(反応液に対する体積比)で入れて3回抽出した後に濃縮し、シリカゲルカラムクロマトグラフィー(クロロホルム:メタノール=9:1)によって図1に示すようにジンセノサイドRdを分離した。
Claims (8)
- 前記の方法は、以下の段階を含むことを特徴とする請求項1に記載の方法:
(1)基質である人参のパナキサジオール系のサポニンを水性溶媒または水性溶媒と有機溶媒との混合液中に溶解させ、酵素としてトリコデルマ属の微生物から分離したペクチナーゼを添加して、加温状態の水浴槽上で撹拌しながら反応させる段階;
(2)前記の基質が完全消失したら、酵素を不活性化させて反応を終了させる段階;および
(3)反応液に酢酸エチルまたはエタノールを添加して抽出した後に濃縮させて、ジンセノサイドRdを分離する段階。 - 前記の基質である人参のパナキサジオール系のサポニンは、ジンセノサイドRb1、Rb2、Rcまたはこれらの混合物中から選択される一種以上であることを特徴とする請求項2に記載の方法。
- 前記のトリコデルマ属の微生物は、トリコデルマアグレシバム(Trichoderma aggressivum)、トリコデルマハルジアナム(Trichoderma harzianum)、トリコデルマリーゼイ(Trichoderma reesei)およびトリコデルマビリデ(Trichoderma viride)からなる群より選択される一種以上であることを特徴とする請求項2に記載の方法。
- 前記の酵素は、基質の量に対して10〜400重量%の量で用いられることを特徴とする請求項2に記載の方法。
- 前記(1)の酵素の反応は、30〜60℃の温度で行われることを特徴とする請求項2に記載の方法。
- 前記(1)の酵素の反応は、1〜48時間行われることを特徴とする請求項2に記載の方法。
- 前記の水性溶媒または水性溶媒と有機溶媒との混合液はpHが3.5〜5.5の範囲であることを特徴とする請求項2に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2015-0147354 | 2015-10-22 | ||
KR1020150147354A KR20170047008A (ko) | 2015-10-22 | 2015-10-22 | 효소적 방법에 의하여 인삼의 사포닌으로부터 진세노사이드 Rd를 선택적으로 제조하는 방법 |
PCT/KR2016/011905 WO2017069565A1 (ko) | 2015-10-22 | 2016-10-21 | 효소적 방법에 의하여 인삼의 사포닌으로부터 진세노사이드 rd를 선택적으로 제조하는 방법 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018531029A JP2018531029A (ja) | 2018-10-25 |
JP2018531029A6 JP2018531029A6 (ja) | 2018-12-13 |
JP6854815B2 true JP6854815B2 (ja) | 2021-04-07 |
Family
ID=58557380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018520414A Active JP6854815B2 (ja) | 2015-10-22 | 2016-10-21 | 酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US10519480B2 (ja) |
EP (1) | EP3351639B1 (ja) |
JP (1) | JP6854815B2 (ja) |
KR (1) | KR20170047008A (ja) |
CN (1) | CN108138210B (ja) |
TW (1) | TWI737638B (ja) |
WO (1) | WO2017069565A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102015044B1 (ko) | 2017-11-14 | 2019-08-27 | 재단법인 진안홍삼연구소 | 효소 및 자외선 UVB를 이용한 진세노사이드 Rd가 강화된 홍삼 농축액 및 그의 제조방법 |
CN113136358B (zh) * | 2021-06-01 | 2023-08-04 | 重庆大学 | 一种提高人参皂苷产量的好氧共培养益生菌发酵工艺 |
CN115449536B (zh) * | 2021-06-09 | 2023-04-25 | 成都普睿法药物研发有限公司 | 黑曲霉发酵液转化Rb1为CK的方法 |
CN114377049A (zh) * | 2022-01-25 | 2022-04-22 | 吉林省御华府生物食品工程有限公司 | 一种人参的提取方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1105781C (zh) * | 1999-03-17 | 2003-04-16 | 金凤燮 | 酶法改变人参皂甙糖基制备人参皂甙的方法 |
CN1477205A (zh) * | 2003-07-10 | 2004-02-25 | 黄亚平 | 生物催化剂转化人参皂甙生产稀有人参皂甙的方法 |
KR20090061107A (ko) * | 2007-12-11 | 2009-06-16 | 메타볼랩(주) | 진세노사이드 f2로의 전환방법 |
KR101753077B1 (ko) | 2010-05-07 | 2017-07-03 | 에스케이바이오랜드 주식회사 | 발효 인삼추출물의 제조방법 및 이를 함유하는 조성물 |
KR101823585B1 (ko) * | 2011-07-01 | 2018-01-31 | 에스케이바이오랜드 주식회사 | 발효 인삼추출물의 제조방법 |
CN102888437B (zh) * | 2011-07-22 | 2014-06-11 | 复旦大学 | 一种利用微生物转化制备人参皂苷Rd的方法 |
KR101427882B1 (ko) | 2012-07-03 | 2014-08-08 | 한국과학기술원 | 플라보박테리엄 존소니에 유래의 신규한 진세노사이드 글리코시다제를 이용한 진세노사이드 Rd 및 F2의 제조방법 |
CN103146592B (zh) * | 2013-01-31 | 2014-06-25 | 河南科技学院 | 一种转化人参皂苷Rb1生成Rd的酵母菌及其应用 |
CN103142669B (zh) * | 2013-03-07 | 2015-07-22 | 安徽丰润生物技术有限公司 | 酶法提取人参皂苷的方法 |
CN103525892A (zh) * | 2013-09-20 | 2014-01-22 | 吉林大学 | 一种快速制备稀有人参皂甙Rd的方法 |
-
2015
- 2015-10-22 KR KR1020150147354A patent/KR20170047008A/ko not_active Application Discontinuation
-
2016
- 2016-10-21 JP JP2018520414A patent/JP6854815B2/ja active Active
- 2016-10-21 EP EP16857822.7A patent/EP3351639B1/en active Active
- 2016-10-21 CN CN201680061963.XA patent/CN108138210B/zh active Active
- 2016-10-21 WO PCT/KR2016/011905 patent/WO2017069565A1/ko active Application Filing
- 2016-10-21 US US15/769,995 patent/US10519480B2/en active Active
- 2016-10-21 TW TW105134028A patent/TWI737638B/zh active
Also Published As
Publication number | Publication date |
---|---|
EP3351639A1 (en) | 2018-07-25 |
KR20170047008A (ko) | 2017-05-04 |
JP2018531029A (ja) | 2018-10-25 |
US20180320212A1 (en) | 2018-11-08 |
EP3351639A4 (en) | 2019-05-15 |
US10519480B2 (en) | 2019-12-31 |
TWI737638B (zh) | 2021-09-01 |
CN108138210B (zh) | 2022-06-03 |
TW201718866A (zh) | 2017-06-01 |
CN108138210A (zh) | 2018-06-08 |
WO2017069565A1 (ko) | 2017-04-27 |
EP3351639B1 (en) | 2020-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6854815B2 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 | |
KR20230157273A (ko) | 효소적 방법에 의하여 인삼의 사포닌으로부터 컴파운드 k 및 컴파운드 y를 선택적으로 제조하는 방법 | |
JP2018531029A6 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドRdを選択的に製造する方法 | |
KR20150059345A (ko) | 진세노사이드 f2의 함량이 증가된 발효 홍삼의 제조방법 및 상기 방법으로 제조된 발효 홍삼 추출물 | |
KR100424438B1 (ko) | 효소적 방법에 의한 진세노사이드 알디의 제조방법 | |
JP6976937B2 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 | |
KR20200121196A (ko) | 컴파운드 k 함량이 증진된 생물전환 홍삼 제조 방법 | |
KR101777673B1 (ko) | 효소를 이용한 진세노사이드 Rd의 제조방법 | |
KR20170027367A (ko) | 효소 및 유기산 처리를 통한 진세노사이드 Rh2, Rk2 및 Rh3 제조방법 | |
JP2018531018A6 (ja) | 酵素的方法によって人参のサポニンからジンセノサイドF2、コンパウンドMcおよびコンパウンドOを選択的に製造する方法 | |
KR20180013526A (ko) | 진세노사이드 Rh1의 제조방법 | |
KR20020058153A (ko) | 효소적 방법에 의한 진세노사이드 f₂의 제조방법 | |
KR100689745B1 (ko) | 알파-갈락토시다제를 이용하는 진세노사이드 제조방법 | |
KR20030043167A (ko) | 나린지나제 효소를 이용한 진세노사이드 에프원의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190927 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200901 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201201 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210216 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210316 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6854815 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |